C. Rex Teeslink
Founder at Advanced Catheter Therapies, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Paul J. Fitzpatrick | M | - |
Advanced Catheter Therapies, Inc.
 Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | 16 years |
| F. Kevin Dye | M | - |
Advanced Catheter Therapies, Inc.
Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | - |
| Dirk V. Hoyns | M | - |
Advanced Catheter Therapies, Inc.
Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | 16 years |
| David A. Belitz | M | - |
Advanced Catheter Therapies, Inc.
Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | - |
| J. Scott Adams | M | - |
Advanced Catheter Therapies, Inc.
Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | - |
| Frank Bunch | M | - |
Advanced Catheter Therapies, Inc.
Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | - |
| Henry Krebs | M | - |
Advanced Catheter Therapies, Inc.
Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| C. Adair | M | - |
Advanced Catheter Therapies, Inc.
Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | 11 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 8 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- C. Rex Teeslink
- Personal Network
